Smart cities must have a vector control component : Health Ministry
Advertisement
New Delhi: The smart cities must have a vector control component which needs to be included in strategic planning for urban development, said a top government official from Ministry of Health & Family Welfare at ASSOCHAM Dialogue on Protecting Communities: Vector Control in Action summit held here today. Globally, around 80 per cent of the entire population is at risk of one or more vector-borne diseases. While 77 per cent of the global burden of communicable disease is attributable to VBDs as well, said Dr N. S. Dharmshaktu, Principal Advisor on Public Health, MoHFW.
“We need web-based reporting on Vector Borne Diseases (VBDs). Also, make malaria treatment training mandatory for Doctors & Public Health Workers,” said Dr Dharmshaktu. Addressing the inaugural address Dr P. K. Sen, Director, NVBDCP, MoHFW said, about 60 per cent decline in Malaria cases in 2018 so far compared to the same time in 2017. With the steady decline of malaria cases in India, the signs are positive that its prevention and control measure are working effectively. Additionally, facilitating the adoption of integrated vector management and ensuring the implementation of vector control services in rural and urban areas can shrink the disease burden much faster in India, added Dr. P. K. Sen.He further said the cases of dengue rising globally whereas mortality has reduced from 3-4 per cent to below 1 per cent, said Dr. P. K. Sen. In his address, ASSOCHAM's secretary general Uday Kumar Varma lauded the commendable work done by the governments, both at the centre and in the states in bringing down the transmission intensity of vector-borne diseases in our country.
He also said that determination on both sides i.e. the government and the private sector would go a long way in further containing the spread of vector-borne diseases and reversing the trend by effectively dealing with challenges like the dearth of skilled manpower and promoting use of latest advancements in medical technology.Dr. Arun Kumar, Head of Environmental Science, Bayer South Asia said, Vector Borne Diseases (VBDs) pose a significant risk to India due to rapid urbanization, increased movement of people and goods & environmental changes. These diseases impede economic development through direct medical costs and indirect costs such as loss of productivity, in addition to enormous mortality. All the common VBDs are preventable and Vector Control along with community education can play a significant role in disease prevention.
At Bayer, we are actively engaged in helping organizations across the globe to sustainably manage insect vectors, which transmit diseases and cause human sickness and mortality. Bayer has recently signed "Zero by 40," a global declaration with the vision to eradicate Malaria by 2040 through research, development and supply of innovative Vector Control solutions, said Dr. Arun Kumar. Matloob Hassan, Director, Azoth Analytics Pvt. Ltd said, Vector-borne diseases pose a major public health problem around the world. Globally, more than 347 million cases of vector-borne diseases including Malaria, Dengue, Chikungunya, Kala-azar, Japanese Encephalitis, Lymphatic Filariasis and Zika, were reported
in the year 2017. Therefore, diminishing their impact is a worldwide priority.
“We need web-based reporting on Vector Borne Diseases (VBDs). Also, make malaria treatment training mandatory for Doctors & Public Health Workers,” said Dr Dharmshaktu. Addressing the inaugural address Dr P. K. Sen, Director, NVBDCP, MoHFW said, about 60 per cent decline in Malaria cases in 2018 so far compared to the same time in 2017. With the steady decline of malaria cases in India, the signs are positive that its prevention and control measure are working effectively. Additionally, facilitating the adoption of integrated vector management and ensuring the implementation of vector control services in rural and urban areas can shrink the disease burden much faster in India, added Dr. P. K. Sen.He further said the cases of dengue rising globally whereas mortality has reduced from 3-4 per cent to below 1 per cent, said Dr. P. K. Sen. In his address, ASSOCHAM's secretary general Uday Kumar Varma lauded the commendable work done by the governments, both at the centre and in the states in bringing down the transmission intensity of vector-borne diseases in our country.
He also said that determination on both sides i.e. the government and the private sector would go a long way in further containing the spread of vector-borne diseases and reversing the trend by effectively dealing with challenges like the dearth of skilled manpower and promoting use of latest advancements in medical technology.Dr. Arun Kumar, Head of Environmental Science, Bayer South Asia said, Vector Borne Diseases (VBDs) pose a significant risk to India due to rapid urbanization, increased movement of people and goods & environmental changes. These diseases impede economic development through direct medical costs and indirect costs such as loss of productivity, in addition to enormous mortality. All the common VBDs are preventable and Vector Control along with community education can play a significant role in disease prevention.
At Bayer, we are actively engaged in helping organizations across the globe to sustainably manage insect vectors, which transmit diseases and cause human sickness and mortality. Bayer has recently signed "Zero by 40," a global declaration with the vision to eradicate Malaria by 2040 through research, development and supply of innovative Vector Control solutions, said Dr. Arun Kumar. Matloob Hassan, Director, Azoth Analytics Pvt. Ltd said, Vector-borne diseases pose a major public health problem around the world. Globally, more than 347 million cases of vector-borne diseases including Malaria, Dengue, Chikungunya, Kala-azar, Japanese Encephalitis, Lymphatic Filariasis and Zika, were reported
in the year 2017. Therefore, diminishing their impact is a worldwide priority.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.